ScripsAmerica's Main Avenue Pharmacy Records $5.2
Post# of 7769
Posted On: 01/05/2015 8:03:12 AM
ScripsAmerica's Main Avenue Pharmacy Records $5.2 Million in Approved Orders for December 2014 Go SCRC! Tut
TYSONS CORNER, VA / ACCESSWIRE / January 5, 2014 / ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $5,280,402 in approved orders during the month of December 2014.
This represents the fourth consecutive month that ScripsAmerica's specialty pharmacy generated over $5 million in sales to close 2014 and puts the pharmacy at an annual run rate over $63 million.
"ScripsAmerica is pleased to announce that Main Avenue Pharmacy recorded a very strong finish to 2014 and we expect this momentum to carry over into the new year. Generating approved orders of $5.28 million during the month of December, when the holidays usually slow sales, is very impressive and a testament to the strength of our specialty pharmacy business. These are very exciting times for ScripsAmerica and its shareholders as we believe that 2015 will be the Company's most successful year to date," stated ScripsAmerica's CEO, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
SOURCE: ScripsAmerica, Inc.
(END) Dow Jones Newswires
January 05, 2015 08:01 ET (13:01 GMT)
TYSONS CORNER, VA / ACCESSWIRE / January 5, 2014 / ScripsAmerica, Inc. (OTCBB: SCRC) today announced that its wholly owned subsidiary, Main Avenue Pharmacy, reported $5,280,402 in approved orders during the month of December 2014.
This represents the fourth consecutive month that ScripsAmerica's specialty pharmacy generated over $5 million in sales to close 2014 and puts the pharmacy at an annual run rate over $63 million.
"ScripsAmerica is pleased to announce that Main Avenue Pharmacy recorded a very strong finish to 2014 and we expect this momentum to carry over into the new year. Generating approved orders of $5.28 million during the month of December, when the holidays usually slow sales, is very impressive and a testament to the strength of our specialty pharmacy business. These are very exciting times for ScripsAmerica and its shareholders as we believe that 2015 will be the Company's most successful year to date," stated ScripsAmerica's CEO, Bob Schneiderman.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
Seal Point Consulting, LLC
888-959-7095
ir@sealpointconsulting.com
SOURCE: ScripsAmerica, Inc.
(END) Dow Jones Newswires
January 05, 2015 08:01 ET (13:01 GMT)
(0)
(0)